Multiple drug resistance, mediated by the expression and activity of ABC-transporters, is a major obstacle to antineoplastic therapy. Normal tissue stem cells and their malignant counterparts share MDR transporter activity as a major mechanism of self-protection. Although MDR activity is upregulated in response to substrate chemotherapeutic agents, it is also constitutively expressed on both normal tissue stem cells and a subset of tumor cells prior to the initiation of therapy, representing a built-in obstacle to therapeutic ratio. Constitutive and induced MDR activity can be detected in cellular subsets of disaggregated tissues, using the fluorescent substrates Rhodamine 123 and Hoechst 33342 for ABCB1 (also known as P-gp and MDR1) and ABCG2 (BCRP1). In this chapter, we will describe the complete procedure for the detection of MDR activity, including: (1) Preparing single-cell suspensions from tumor and normal tissue specimens; (2) An efficient method to perform cell surface marker staining on large numbers of cells; (3) Flow cytometer setup and controls; (4) Simultaneous measurement of Hoechst 33342 and Rhodamine123 transport; and (5) Data acquisition and analysis.
nervous system they are expressed by capillary endothelial cells, forming the blood brain barrier ( 1 ) . In the gut they are expressed by villus tip enterocytes of the small intestine ( 2 ) , limiting the bioavailability of substrate drugs. In stem cells, MDR transporters, principally ABCG2 (also known as breast cancer resistance protein 1 (BCRP1)) and ABCB1 (also known as P-glycoprotein (P-gp) and multiple drug resistance protein 1 (MDR1)), operate at the single cell level, rather than at the tissue level, excluding xenobiotics and other toxins and making stem cells among the most resilient cells in the body. ABC transporters may be constitutively expressed, as they are in some stem cell populations ( 3 ) , or may be induced by exposure to substrate, as they are in memory T lymphocytes ( 4 ) .
MDR activity can be detected and quantified by exclusion of fluorescent substrates. The association of constitutive MDR expression with normal tissue stem cells (sometimes called adult stem cells) was first demonstrated by Lansdorp, who showed that the most primitive hematopoietic cells could be isolated from the bone marrow (BM) by sorting for cells which excluded the lipophilic, cationic dye rhodamine 123 ( 5 ) . Years later, this phenomenon was rediscovered by Goodell while sorting BM cells on the basis of DNA content (cell cycle). After staining BM cells with the membrane permeant DNA stain Hoechst 33342 she noted, in addition to the usual cell cycle populations, a very small population of viable cells which excluded the Hoechst dye. In very careful experiments, she determined that this population was highly enriched for cells capable of reconstituting hematopoiesis in radiation-ablated mice ( 3 ) . She called these cells Side Population cells because of their location on the far left side of blue fluorescence vs. red fluorescence histograms. Today, Hoechst 33342 excluding cells are commonly referred to as side population cells. Such cells can be found in a wide variety of tissues, and the side population strategy has been useful for isolating cells with high regenerative capacity from hematopoietic ( 3, 5, 6 ) , airway ( 7 ) , pituitary ( 8 ) , small intestine ( 9 ) , and testicular ( 10 ) tissues. However, given the wide array of biological functions that ABC transporters serve, and the fact that they are sometimes induced in transporter-negative cells by substrate exposure, the caveat must be given that MDR expression does not unequivocally identify stem cells and conversely, its absence does not rule out the self-renewing capacity most characteristic of stemness.
Multiple drug resistance transporters are so named because they were first discovered in the context of antineoplastic therapy ( 11 ) . Their discovery solved the conundrum posed by the observation that cancer cells which developed resistance to a
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particular chemotherapeutic agent became simultaneously resistant to a wide variety of unrelated agents, including drugs with entirely different mechanisms of action. Today we know that MDR is constitutively expressed by a subset (usually a small subset) of neoplastic cells prior to treatment with substrate drugs. Treatment results in selection for drug excluding MDR active cells by a number of mechanisms, including regional gene activation ( 12 ) , gene amplification ( 13 ) , and modification of histone acetylation at the ABCG2 locus ( 14 ) . Recently it has been suggested that MDR activity in some cancers is regulated by the hedgehog signaling pathway ( 15, 16 ) , a key pathway in embryonic morphogenesis ( 17 ) . Further, although the mechanism remains unclear, there are data linking MDR expression to radiation resistance ( 18 ) .
MDR activity has been investigated in multiple types of cancer as a possible means of identifying the cancer stem cell. The vast majority of work has been done in cell lines, which have undergone generations of selection for characteristics favorable to in vitro growth in the absence of host-and therapy-mediated selective pressures. Not all tumorigenic cancer cell lines exhibit a side population. Investigators working with SP + cell lines derived from ovarian cancer ( 19 ) , breast cancer ( 20 ) , glioma ( 21 ) , prostate ( 22 ) , and thyroid cancer ( 23 ) all found enhanced tumorigenicity or in vitro clonogenicity in sorted side population cells. Harris et al. ( 21 ) and Mitsutake et al. ( 23 ) found that non-SP cells could give rise to SP cells. In contrast, Lichtenauer et al. found neither growth nor survival advantage in SP cells sorted from an adrenocortical carcinoma cell line ( 24 ) . Our own data in primary breast cancer isolates support plasticity in MDR expression. Sorted CD44+ CD90+ ABCG2− breast cancer cells gave rise to heterogeneous tumors which included a subset of ABCG2+ cells when explanted to NOD/SCID mice ( 25 ) . Therefore, the caveat given for normal stem cells, that MDR activity and stemness are not one in the same, holds for neoplastic cells as well ( 26 ) . Although MDR activity is upregulated in response to substrate chemotherapeutic agents, it is also constitutively expressed on both normal tissue stem cells and a subset of tumor cells prior to the initiation of therapy ( 19, [25] [26] [27] , representing a built-in obstacle to therapeutic ratio ( 28 ) . The take-home message is that a cancer cell which is both self-renewing (i.e., tumorigenic) and protected by MDR transporters constitutes a very difficult therapeutic target, having much in common with normal tissue stem cells. Thus, detection and isolation of MDR active cells by simultaneous measurement of rhodamine 123 and Hoechst 33342 transport ( 29 ) represents an important tool for investigation of those cancer cells capable of therapy resistance, dormancy, and reactivation. (a) 41.5 g Ammonium chloride.
(b) 5.0 g Potassium bicarbonate.
(c) 400 mL Glass distilled water.
(d) pH to 7.2-7.4 with 1 M HCl or NaOH as needed.
(e) QS to 500 mL with distilled water.
(f) Dilute with distilled water to 1× prior to use. 13 . Hemacytometer (VWR Scientific 48312-002). 1. Place tissue into a tared 60-mm Petri dish.
Trypan
2. If desired remove a small piece for histology (paraffin and OCT embedding).
3. Record the weight of remaining tissue.
4. Finely mince using sterile paired scalpels. Add a few drops of collagenase/DNase solution while mincing to prevent tissue from drying ( Fig. 1 ) .
5.
Place a 70-m m cell strainer in the mouth of a 50-mL polypropylene conical tube labeled "Filtrate."
6. Using a scalpel, a 10-mL pipette and PBS-A plus 2% calf serum (PBS-A-CS), transfer all tissue into the cell strainer. Repeat until all tissue fragments have been removed from the Petri dish, pipetting PBS-A-CS vigorously against the cell strainer to release individual cells ( see Notes 1 and 2 ).
7. Bring volume of Filtrate tube to 50 mL with PBS-A-CS, centrifuge at 400 × g for 10 min, and discard supernatant. Resuspend in 2 mL PBS-A-CS and hold on ice.
8. Using a scalpel, transfer minced tissue in the strainer to an additional 50-mL polypropylene conical tube containing 10 mL collagenase/DNase solution. Label "Digest."
Methods

Tissue Collection and Digestion
9. Place Digest tube in shaking waterbath (e.g., Bellydancer, Stovall Life Science) at 37°C for 30 min, maximum agitation setting.
10. Place a new 70-m m cell strainer in the mouth of the conical tube labeled Filtrate.
11. Using a 10-mL pipette, transfer material from the Digest tube into the cell strainer on the Filtrate tube.
12. Add 10 mL PBS-A-CS to the Digest tube and transfer any remaining tissue to the cell strainer. Repeat if necessary.
13. Using a scalpel, transfer the undigested material from the cell strainer back into the Digest tube.
14. Add 10 mL collagenase/DNase solution and return Digest tube to the shaking 37°C waterbath for 30 min.
15. Bring volume of Filtrate tube to 50 mL with PBS-A-CS, centrifuge at 400 × g for 10 min, and discard supernatant. Resuspend in 2 mL PBS-A-CS and hold on ice. 16 . Repeat steps 10 and 11 . The tissue was minced into fine fragments using paired scalpels ( b ). A few drops of collagenase/DNase were added to the minced tissue to prevent drying and clumping. PBS-A is added to the Petri dish ( c ) and carefully pipetted through a cell strainer into a 50-mL conical tube ( d , Filtrate). Tissue remaining in the strainer is digested with collagenase/DNase and the process is repeated as necessary . 2. When the incubation is complete, wash the cells once (400 × g , 10 min) with ice-cold PBS-A-CS and resuspend to 5-10 × 10 6 cells/mL in ice cold PBS-A 10% CS ( see Note 13 ).
3. Add Propidium Iodide, 10 m g/mL final concentration, as a viability dye ( see Note 14 ).
4. Strain cells immediately prior to flow cytometric acquisition through a 70-m m cap filter.
Extracellular Staining
Simultaneous Measurement of Hoechst 33342 and
Rhodamine 123 Dye Transport (Fig. 2 
Instrument Setup and MDR Standards
IgG Capture Bead Staining Vincristine had no effect on either cell line, whereas the ABCG2 specific inhibitor, fumitremorgin (1 m M), only inhibited Ho33342 transport in parental K562 (native ABCG2 mediated transport) and had no effect on Ho33342 transport through ABCB1. Verapamil (50 m M, a MDR nonspecific inhibitor) blocked SP phenotype in both cell lines. R123 transport was limited to cells with ABCB1 expression (K562-G185 only), the parental K562 had no constitutive ABCB1 activity or expression. The R123 dull phenotype was reversed by the addition of either CsA or verapamil but was not blocked by the addition of ABCG2-specific inhibitor fumitremorgin. Fig. 3 ) . For the side population itself, blue fluorescence intensity should be slightly greater than red fluorescence intensity, displacing the side population slightly upward on the histogram ( 31 ) .
5.
Acquire unstained cells or beads first, and then each single stained sample (bead or cells) from the shortest emission wavelength (R123 stained cells) to the longest (e.g., CD45 APCCy7). We perform data analysis offline, using VenturiOne software (Applied Cytometry) which has been designed to accommodate very large datafiles. We create an analysis template into which we load our spectrally compensated data. Our strategy usually proceeds in three steps: 1. First we eliminate sources of interference with logical gates. These include cell-cell doublets and clusters, subcellular debris, and dead cells (Fig. 5 ) .
2. Next we decide on our classifier parameters. In this example CD45 expression (rt. 5 ) serves as a primary classifier, and Hoechst dye exclusion (Fig. 6 ) is a secondary (branching) classifier. Fig. 4 . Instrument set up for Hoechst 33342 detection using cell lines as process controls. Parental K562 and ABCB1transfected K562-G185 cells were used as low-negative and positive controls, respectively. A gating strategy was used to restrict analysis to singlet viable (PI negative) cells. Approximately 650,000 viable singlet events were acquired for both samples. The majority of parental K562 had no Ho33342 transport. The majority of events had uniform Ho33342 fluorescence in both blue and red detection PMTs, representing cells with 2N DNA. Almost all ABCB1 transfected cells transported Ho433342 and therefore exhibited the side population (SP) phenotype, with greater blue than red fluorescence. Only a small minority of K562-G185 cells failed to transport Ho33342 and therefore had fluorescence intensities characteristic of 2N DNA cells .
Data Analysis
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3. Next outcomes , parameters to be measured on each population defined by the classifiers, are determined. In this case (Fig. 6 ) the outcome variables are R123 dye efflux, CD90 and EpCAM expression, and light scatter ( see Note 26 ).
4.
Lymphocytes are often present in tumor specimens and are identifiable by bright CD45 expression and low light scatter (Fig. 5 ) . Since virtually none of these cells transports Hoechst 33342, the dye reaches the nucleus, where it binds to DNA stoichiometrically. The great majority of lymphocytes have 2N DNA content, but a distinct population of cycling cells can also be seen (Fig. 7 ) . A population with very low blue and red fluorescence is often present as a source of artifact in digested tissue (Fig. 8 ) . These acellular events have sufficient light scatter to trigger the cytometer to acquire a pulse, but have no DNA content (which also prevents them from being eliminated by PI staining). Another potential source of artifact is cells with laddered DNA (Fig. 8 ) , the result of apoptosis-induced endonuclease release. The feature which distinguished them from bona fide side population cells is that cells with degraded DNA lie on the blue/red diagonal, whereas side population cells have greater blue than red fluorescence and are therefore slightly above the diagonal.
5.
There is some confusion in the literature concerning the specificity of the side population, with early reports attributing the side population exclusively to cells expressing the ABCG2 transporter. Figure 2 shows results obtained with K562 cells (parent) and cells transfected with an ABCB1 vector (K562 G185). Surface staining with anti-ABCB1 (UIC2) and anti-ABCG2 antibodies ( see Note 27 ), and real-time PCR performed on these cells (not shown) confirmed that both cell lines had low ABCG2 expression but that only the transfectant had detectable ABCB1. The Instrument was set up using parental and ABCB1 transfected cell lines and presence of a battery of inhibitors. Two important points emerge from the analysis: (1) Both ABCG2 (parental and transfected) and ABCB1 (transfected only) mediate Hoechst 33342 transport and therefore confer the side population phenotype; (2) The transporters responsible for the side population and Fig. 7 . Identification of "side population" cells by Ho33342 transport in freshly digested tumor tissue. Events were gated as shown in Fig. 5 . Lymphocytes identified as CD45bright/EpCAM negative (Fig. 5 ) were largely homogeneous for Ho33342 uptake and DNA staining (2N, left histogram); no "side population" was detected. Nonhematopoietic (CD45−) cells evidenced a significant "side population" accounting for 2.3% of events (center histogram). Cells with 2N and >2N DNA content (non-Ho33342 transporting cells) comprised the majority of cells. Abrogation of the "side population" (right histogram) by the addition of MDR inhibitors cyclosporine and fumitremorgin confirms that Ho33342 elimination is mediated by MDR transporters. Events in the lower left-hand corner are not Ho33342 transporting cells, but rather events that triggered on FSC but lack DNA. Another commonly seen artifact is illustrated in the bottom histogram. The diagonal streak exhibits equal red and blue fluorescence and represents cells with degraded DNA, as is seen in early apoptotic cells. In this example, the diagonal streak was not abrogated by the addition of MDR inhibitors . necessary because cells that are killed during the disaggregation procedure release viscous DNA strands which entrap live cells.
A and B and C
2. Occasionally, tumors are too sclerotic for the minced pieces to be disaggregated through a nylon cell strainer. In these cases we substitute a stainless tissue sieve with a 10-mesh screen overlayed with a 100-mesh screen. Tissue fragments are forced through the screen with a glass pestle ( see Subheading 2 ).
3. Treatment with ammonium chloride lyses red blood cells. This step may be omitted if sample is not visually contaminated with red blood cells.
4. DNase requires Ca 2+ or Mg 2+ for its activity.
5. Addition of mouse serum, which contains mouse immunoglobulins, blocks nonspecific binding of murine monoclonal antibodies.
6. We refer to this as a dry the pellet elsewhere in the protocol. Cells pelleted in a 15-mL conical tube and aspirated dry actually contain anywhere from 10 to 50 m L of residual liquid.
7. The choice of antibodies and fluorochromes is specific to the question being addressed and the available instrumentation, and can be modified at will. The order of antibody addition may influence staining as binding occurs very rapidly, and sequential addition of many antibodies progressively reduces the concentration of individual antibodies in the mixture ( 26, 33 ) . 10. Make all inhibitors at 1,000× final concentration to avoid adding an excessive amount of the vehicle (EtOH for cyclosporine).
11. Prepare tubes with inhibitors ahead of time and transfer cells immediately after the addition of R123 and Ho33342.
12. It is useful, especially when first establishing this assay, to use reference cell lines known to express MDR activity. We use the chronic myelogenous leukemia cell line K562 (low MDR activity) and K562 cells transfected with the ABCB1 vector G185 (very high MDR activity) ( 35 ) as process controls (Fig. 4 ) , incubated in the absence and presence of inhibitors (Fig. 2 ) . The G185 transfectants were kindly provided by Dr. Suresh Ambudkar.
13. Keep on ice under aluminum foil until acquisition; maximum wait time before acquisition is 1 h. Holding cells longer will result in loss of side population cells.
14. Viable cells exclude PI. PI stains dead and dying cells very brightly and facilitates their removal from the analysis. Since it is broadly fluorescent, PI-positive cells must be removed from the analysis with a logical gate (Fig. 4 ) .
15
. Single stained compensation standards are essential for correct spectral compensation. We find it best to use peripheral blood mononuclear cells incubated with rhodamine 123 (per earlier protocol) for the FL1 standard, integrally stained Calibrite beads for PE and APC, and Ig capture beads (Comp-Beads) for antibodies conjugated to tandem dyes. Hoechst 33342 staining does not require spectral compensation. It should be noted that R123, which is acquired with the same filter as is used for FITC (530/40 BP), has more spillover into the PE channel than FITC and therefore requires more spectral compensation. 16 . Beads do not pack as tightly as cells, so care must be taken not to aspirate the beads.
17. Sonication is not essential but is very useful because it disaggregates bead clumps better than vortexing or refluxing.
18. Tandem dyes are easily degraded by exposure to light. Reagents, stained cells, and stained beads must be carefully protected from ambient light. We perform staining in an unilluminated biological safety cabinet, and cover stained cells and beads with aluminum foil to minimize light exposure. 19 . Addition of mouse serum prevents clumping of beads due to antibody crosslinking.
20. Negative beads are not required for some automated compensation algorithms, such as those implemented on Beckman-Coulter instruments or in VenturiOne software.
21.
Decanting and blotting must be done in one smooth motion to prevent loss of beads. 22 . The sample station is prechilled and kept at 4°C during the entire acquisition.
23. Determining balanced PMT settings is an art in itself and has been addressed by us elsewhere ( 32 ) . Once these settings have been established, and bead target channels have been determined, they can be reproduced from experiment to experiment by adjusting PMT voltage to place the brightest peak of the Rainbow particles in the predetermined target channel. The intensity of Hoechst 33342 staining will vary from specimen to specimen, because it is measured on a linear scale and is highly dependent on the total amount of DNA in the sample. PMT voltages for the Hoechst Red and Blue channels are adjusted for each sample to place the median fluorescence of the 2N population at about channel 192 (of 255) (Fig. 4 ) .
Our
MoFlo is an analog model in which log or linear modes of amplification are user selected. Newer digital flow cytometers use high-resolution linear amplification exclusively and logarithmic transformations are performed mathematically.
25. CD45− Lin− CD44+ side population cells may be very rare events. We routinely acquire 10 million events per sample at rates not exceeding 10,000 events/second, to assure sufficient cells for subset analysis. 26 . Which parameters are used to define classifiers, and which define outcomes is somewhat plastic and depends on the goal of the analysis. For example, one could classify cells into several populations on the basis of CD90 and EpCAM expression and then look at dye efflux as an outcome. The classifier/outcome strategy has the advantages of focusing the analysis and avoiding the all possible permutations problem inherent in multiparameter data files.
27. These antibodies interfere with transporter activity and cannot be used with dye transport assays.
